Table 2.

Bilirubin, platelet levels, and immunosuppression in patients with extensive chronic GVHD after PBSCT and BMT




Bilirubin, μmol/L (range)





Immunosuppression status, no.

Time to cessation of IS, d after cGVHD (range)
Platelets, ×109/L (range)
Response to prednisolone, no.
Not stopped

No.
None
Partial
Full
Stopped
PBSC   31   15 (5-255)   137 (9-300)   12   8   11   8   23   963 (405-2182)  
BM
 
19
 
16 (4-134)
 
166 (25-300)
 
4
 
5
 
10
 
5
 
14
 
1265 (526-2096)
 



Bilirubin, μmol/L (range)





Immunosuppression status, no.

Time to cessation of IS, d after cGVHD (range)
Platelets, ×109/L (range)
Response to prednisolone, no.
Not stopped

No.
None
Partial
Full
Stopped
PBSC   31   15 (5-255)   137 (9-300)   12   8   11   8   23   963 (405-2182)  
BM
 
19
 
16 (4-134)
 
166 (25-300)
 
4
 
5
 
10
 
5
 
14
 
1265 (526-2096)
 

PBSCT indicates peripheral stem-cell transplantation; BMT, bone marrow transplantation; and IS, immunosuppression. P was not significant for any of the variables.

Close Modal

or Create an Account

Close Modal
Close Modal